About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Atmtm1Mfl
targeted mutation 1, Martin F Lavin
MGI:2181756
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Atmtm1Mfl/Atmtm1Mfl involves: 129T2/SvEms * C57BL/6J MGI:2181774
ht2
Atmtm1Mfl/Atm+ involves: 129T2/SvEms * C57BL/6J MGI:3702914


Genotype
MGI:2181774
hm1
Allelic
Composition
Atmtm1Mfl/Atmtm1Mfl
Genetic
Background
involves: 129T2/SvEms * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Atmtm1Mfl mutation (3 available); any Atm mutation (169 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 50% mortality by 40 weeks of age

growth/size/body
• smaller size persists through adulthood
• 20% growth reduction in males and 18% reduction in females from birth to 45 days of age
• usually found in mice dying after 40 weeks of age

neoplasm
• mice dying after 40 weeks of age usually have tumors that are not thymic lymphomas
• found in all mice dying before 40 weeks
• diverse cell types involved
• spongy tumors with a high proportion of cells undergoing apoptosis

immune system
• occasional increase in thymocyte size
• lymph node T cells are primarily at early stages of development
• randomly observed increases in single positive T cells
• 10% reduction in thymocytes
• 30-50% reduction in thymocytes expressing alpha and beta T cell receptors or CD3
• usually found in mice dying after 40 weeks of age
• in mice under 40 weeks of age

cellular
• loss of spermatids
• degenerating spermatocytes
• 3 fold increase in radiation induced chromosomal aberrations
• increased sensitivity of thymocytes and splenocytes to ionizing radiation

reproductive system
• tubules disrupted
• poorly developed
• disrupted
• lack of maturing follicles and oocytes
• disrupted spermatogenesis
• loss of spermatids
• degenerating spermatocytes

nervous system
N
• no gross neuronal degeneration at time points between 2 and 16 months of age
• survival of Purkinje cells in culture less than 60% of controls at 4 days and about 40% at 10 day
• survival of cultured cells improves if cultured with cerebellar astroglial cells
• develop simpler dendritic arboritization with reduced secondary branching
• nitroxide free radicals improve survival and arborization

endocrine/exocrine glands
• 10% reduction in thymocytes
• 30-50% reduction in thymocytes expressing alpha and beta T cell receptors or CD3
• tubules disrupted
• poorly developed
• found in all mice dying before 40 weeks
• diverse cell types involved
• spongy tumors with a high proportion of cells undergoing apoptosis

hematopoietic system
• 10% reduction in thymocytes
• 30-50% reduction in thymocytes expressing alpha and beta T cell receptors or CD3
• usually found in mice dying after 40 weeks of age
• lymph node T cells are primarily at early stages of development
• randomly observed increases in single positive T cells
• in mice under 40 weeks of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
ataxia telangiectasia DOID:12704 OMIM:208900
J:69726




Genotype
MGI:3702914
ht2
Allelic
Composition
Atmtm1Mfl/Atm+
Genetic
Background
involves: 129T2/SvEms * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Atmtm1Mfl mutation (3 available); any Atm mutation (169 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• elevated tumor incidence
• average age at onset 18.6 months
• varying tumor types including dermatoid cysts
• 32% of total
• half of sarcomas are in Mammary glands

reproductive system

endocrine/exocrine glands





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/09/2024
MGI 6.23
The Jackson Laboratory